1. Home
  2. VNRX vs BRID Comparison

VNRX vs BRID Comparison

Compare VNRX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • BRID
  • Stock Information
  • Founded
  • VNRX N/A
  • BRID 1932
  • Country
  • VNRX United States
  • BRID United States
  • Employees
  • VNRX N/A
  • BRID N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BRID Specialty Foods
  • Sector
  • VNRX Health Care
  • BRID Consumer Staples
  • Exchange
  • VNRX Nasdaq
  • BRID Nasdaq
  • Market Cap
  • VNRX 68.3M
  • BRID 70.3M
  • IPO Year
  • VNRX N/A
  • BRID N/A
  • Fundamental
  • Price
  • VNRX $0.60
  • BRID $7.91
  • Analyst Decision
  • VNRX Strong Buy
  • BRID
  • Analyst Count
  • VNRX 4
  • BRID 0
  • Target Price
  • VNRX $3.50
  • BRID N/A
  • AVG Volume (30 Days)
  • VNRX 196.8K
  • BRID 3.7K
  • Earning Date
  • VNRX 08-14-2025
  • BRID 08-22-2025
  • Dividend Yield
  • VNRX N/A
  • BRID N/A
  • EPS Growth
  • VNRX N/A
  • BRID N/A
  • EPS
  • VNRX N/A
  • BRID N/A
  • Revenue
  • VNRX $1,319,252.00
  • BRID $224,673,000.00
  • Revenue This Year
  • VNRX $274.46
  • BRID N/A
  • Revenue Next Year
  • VNRX $212.60
  • BRID N/A
  • P/E Ratio
  • VNRX N/A
  • BRID N/A
  • Revenue Growth
  • VNRX 35.10
  • BRID N/A
  • 52 Week Low
  • VNRX $0.40
  • BRID $7.35
  • 52 Week High
  • VNRX $0.94
  • BRID $11.95
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 39.24
  • BRID 61.67
  • Support Level
  • VNRX $0.64
  • BRID $7.36
  • Resistance Level
  • VNRX $0.73
  • BRID $7.73
  • Average True Range (ATR)
  • VNRX 0.04
  • BRID 0.18
  • MACD
  • VNRX -0.00
  • BRID 0.06
  • Stochastic Oscillator
  • VNRX 19.34
  • BRID 74.32

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: